BioCentury
ARTICLE | Clinical News

Citicoline: Began Phase II/III trials

April 11, 1994 7:00 AM UTC

Interneuron Pharmaceuticals Inc. (IPIC), Lexington, Mass. Product: Citicoline, providing cytidine and choline for damaged brain cell membranes Indication: Ischemic stroke within 24 hours of onset Stat...